https://consumer.healthday.com/olokizumab-tops-placebo-for-ra-patients-receiving-methotrexate-2657895099.html
0
0
8/25/22 at 3:58pm
Organization
Healthday.com
Author
Physician’s Briefing Staff
25 words
0
Comments
Olokizumab superior to placebo and noninferior to adalimumab in producing ACR20 response at 12 weeks
You are the first to view
Create an account
or login to join the discussion